WT1 and acute myeloid leukemia: Next, WT1/HLA-A2-specific CTL (hereon abbreviated as WT1-CTL) cytotoxicity was assessed against a panel of HLA-A*02:01-positive AML cell lines: OCI-AML2, OCI-AML3, and THP-1.